CN Patent
CN107793417B — 吡咯并[2,3-d]嘧啶类化合物及其盐,及制备方法和药用用途
Assigned to Fudan University · Expires 2020-06-09 · 6y expired
What this patent protects
本发明属有机化学和药物合成领域,涉及一类吡咯并[2,3‑d]嘧啶化合物及其盐,该类化合物及其盐对黏着斑激酶具有显著的抑制作用,可用于制备治疗黏着斑激酶相关疾病的药物,特别是可用于制备治疗黏着斑激酶高表达相关肿瘤的药物。
USPTO Abstract
本发明属有机化学和药物合成领域,涉及一类吡咯并[2,3‑d]嘧啶化合物及其盐,该类化合物及其盐对黏着斑激酶具有显著的抑制作用,可用于制备治疗黏着斑激酶相关疾病的药物,特别是可用于制备治疗黏着斑激酶高表达相关肿瘤的药物。
Drugs covered by this patent
- Zykadia (ceritinib) · Novartis
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.